Chapter/Section Purchase

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fibromyalgia Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Cymbalta (Duloxetine)
1.2.3 Savella (Milnacipran)
1.2.4 Lyrica (Pregabalin)
1.2.5 Pancuronium
1.2.6 Others
1.3 Market by Application
1.3.1 Global Fibromyalgia Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Fibromyalgia Therapeutics Market Perspective (2017-2028)
2.2 Fibromyalgia Therapeutics Growth Trends by Region
2.2.1 Fibromyalgia Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Fibromyalgia Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Fibromyalgia Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Fibromyalgia Therapeutics Market Dynamics
2.3.1 Fibromyalgia Therapeutics Industry Trends
2.3.2 Fibromyalgia Therapeutics Market Drivers
2.3.3 Fibromyalgia Therapeutics Market Challenges
2.3.4 Fibromyalgia Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fibromyalgia Therapeutics Players by Revenue
3.1.1 Global Top Fibromyalgia Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Fibromyalgia Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Fibromyalgia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fibromyalgia Therapeutics Revenue
3.4 Global Fibromyalgia Therapeutics Market Concentration Ratio
3.4.1 Global Fibromyalgia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fibromyalgia Therapeutics Revenue in 2021
3.5 Fibromyalgia Therapeutics Key Players Head office and Area Served
3.6 Key Players Fibromyalgia Therapeutics Product Solution and Service
3.7 Date of Enter into Fibromyalgia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fibromyalgia Therapeutics Breakdown Data by Type
4.1 Global Fibromyalgia Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Fibromyalgia Therapeutics Forecasted Market Size by Type (2023-2028)
5 Fibromyalgia Therapeutics Breakdown Data by Application
5.1 Global Fibromyalgia Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Fibromyalgia Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Fibromyalgia Therapeutics Market Size (2017-2028)
6.2 North America Fibromyalgia Therapeutics Market Size by Type
6.2.1 North America Fibromyalgia Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Fibromyalgia Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Fibromyalgia Therapeutics Market Share by Type (2017-2028)
6.3 North America Fibromyalgia Therapeutics Market Size by Application
6.3.1 North America Fibromyalgia Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Fibromyalgia Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Fibromyalgia Therapeutics Market Share by Application (2017-2028)
6.4 North America Fibromyalgia Therapeutics Market Size by Country
6.4.1 North America Fibromyalgia Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Fibromyalgia Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Fibromyalgia Therapeutics Market Size (2017-2028)
7.2 Europe Fibromyalgia Therapeutics Market Size by Type
7.2.1 Europe Fibromyalgia Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Fibromyalgia Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Fibromyalgia Therapeutics Market Share by Type (2017-2028)
7.3 Europe Fibromyalgia Therapeutics Market Size by Application
7.3.1 Europe Fibromyalgia Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Fibromyalgia Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Fibromyalgia Therapeutics Market Share by Application (2017-2028)
7.4 Europe Fibromyalgia Therapeutics Market Size by Country
7.4.1 Europe Fibromyalgia Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Fibromyalgia Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fibromyalgia Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Fibromyalgia Therapeutics Market Size by Type
8.2.1 Asia-Pacific Fibromyalgia Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Fibromyalgia Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Fibromyalgia Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Fibromyalgia Therapeutics Market Size by Application
8.3.1 Asia-Pacific Fibromyalgia Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Fibromyalgia Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Fibromyalgia Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Fibromyalgia Therapeutics Market Size by Region
8.4.1 Asia-Pacific Fibromyalgia Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Fibromyalgia Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Fibromyalgia Therapeutics Market Size (2017-2028)
9.2 Latin America Fibromyalgia Therapeutics Market Size by Type
9.2.1 Latin America Fibromyalgia Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Fibromyalgia Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Fibromyalgia Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Fibromyalgia Therapeutics Market Size by Application
9.3.1 Latin America Fibromyalgia Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Fibromyalgia Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Fibromyalgia Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Fibromyalgia Therapeutics Market Size by Country
9.4.1 Latin America Fibromyalgia Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Fibromyalgia Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fibromyalgia Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Fibromyalgia Therapeutics Market Size by Type
10.2.1 Middle East & Africa Fibromyalgia Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Fibromyalgia Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Fibromyalgia Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Fibromyalgia Therapeutics Market Size by Application
10.3.1 Middle East & Africa Fibromyalgia Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Fibromyalgia Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Fibromyalgia Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Fibromyalgia Therapeutics Market Size by Country
10.4.1 Middle East & Africa Fibromyalgia Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Fibromyalgia Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Fibromyalgia Therapeutics Introduction
11.1.4 Pfizer Revenue in Fibromyalgia Therapeutics Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Fibromyalgia Therapeutics Introduction
11.2.4 Eli Lilly Revenue in Fibromyalgia Therapeutics Business (2017-2022)
11.2.5 Eli Lilly Recent Developments
11.3 Actavis
11.3.1 Actavis Company Details
11.3.2 Actavis Business Overview
11.3.3 Actavis Fibromyalgia Therapeutics Introduction
11.3.4 Actavis Revenue in Fibromyalgia Therapeutics Business (2017-2022)
11.3.5 Actavis Recent Developments
11.4 Merck Sharp and Dohme
11.4.1 Merck Sharp and Dohme Company Details
11.4.2 Merck Sharp and Dohme Business Overview
11.4.3 Merck Sharp and Dohme Fibromyalgia Therapeutics Introduction
11.4.4 Merck Sharp and Dohme Revenue in Fibromyalgia Therapeutics Business (2017-2022)
11.4.5 Merck Sharp and Dohme Recent Developments
11.5 Daiichi Sankyo
11.5.1 Daiichi Sankyo Company Details
11.5.2 Daiichi Sankyo Business Overview
11.5.3 Daiichi Sankyo Fibromyalgia Therapeutics Introduction
11.5.4 Daiichi Sankyo Revenue in Fibromyalgia Therapeutics Business (2017-2022)
11.5.5 Daiichi Sankyo Recent Developments
11.6 Innovative Med Concepts
11.6.1 Innovative Med Concepts Company Details
11.6.2 Innovative Med Concepts Business Overview
11.6.3 Innovative Med Concepts Fibromyalgia Therapeutics Introduction
11.6.4 Innovative Med Concepts Revenue in Fibromyalgia Therapeutics Business (2017-2022)
11.6.5 Innovative Med Concepts Recent Developments
11.7 Meda
11.7.1 Meda Company Details
11.7.2 Meda Business Overview
11.7.3 Meda Fibromyalgia Therapeutics Introduction
11.7.4 Meda Revenue in Fibromyalgia Therapeutics Business (2017-2022)
11.7.5 Meda Recent Developments
11.8 Meiji Seika
11.8.1 Meiji Seika Company Details
11.8.2 Meiji Seika Business Overview
11.8.3 Meiji Seika Fibromyalgia Therapeutics Introduction
11.8.4 Meiji Seika Revenue in Fibromyalgia Therapeutics Business (2017-2022)
11.8.5 Meiji Seika Recent Developments
11.9 Switch Biotech
11.9.1 Switch Biotech Company Details
11.9.2 Switch Biotech Business Overview
11.9.3 Switch Biotech Fibromyalgia Therapeutics Introduction
11.9.4 Switch Biotech Revenue in Fibromyalgia Therapeutics Business (2017-2022)
11.9.5 Switch Biotech Recent Developments
11.10 Theravance
11.10.1 Theravance Company Details
11.10.2 Theravance Business Overview
11.10.3 Theravance Fibromyalgia Therapeutics Introduction
11.10.4 Theravance Revenue in Fibromyalgia Therapeutics Business (2017-2022)
11.10.5 Theravance Recent Developments
11.11 Zynerba Pharmaceuticals
11.11.1 Zynerba Pharmaceuticals Company Details
11.11.2 Zynerba Pharmaceuticals Business Overview
11.11.3 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Introduction
11.11.4 Zynerba Pharmaceuticals Revenue in Fibromyalgia Therapeutics Business (2017-2022)
11.11.5 Zynerba Pharmaceuticals Recent Developments
11.12 Tonix Pharmaceuticals Holding Corp. (TNXP)
11.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details
11.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview
11.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Introduction
11.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Therapeutics Business (2017-2022)
11.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Developments
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Company Details
11.13.2 Daiichi Sankyo Business Overview
11.13.3 Daiichi Sankyo Fibromyalgia Therapeutics Introduction
11.13.4 Daiichi Sankyo Revenue in Fibromyalgia Therapeutics Business (2017-2022)
11.13.5 Daiichi Sankyo Recent Developments
11.14 Forest Pharmaceuticals, Inc.
11.14.1 Forest Pharmaceuticals, Inc. Company Details
11.14.2 Forest Pharmaceuticals, Inc. Business Overview
11.14.3 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Introduction
11.14.4 Forest Pharmaceuticals, Inc. Revenue in Fibromyalgia Therapeutics Business (2017-2022)
11.14.5 Forest Pharmaceuticals, Inc. Recent Developments
11.15 Boehringer Ingelheim GmbH
11.15.1 Boehringer Ingelheim GmbH Company Details
11.15.2 Boehringer Ingelheim GmbH Business Overview
11.15.3 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Introduction
11.15.4 Boehringer Ingelheim GmbH Revenue in Fibromyalgia Therapeutics Business (2017-2022)
11.15.5 Boehringer Ingelheim GmbH Recent Developments
11.16 Pierre Fabre Mdicament
11.16.1 Pierre Fabre Mdicament Company Details
11.16.2 Pierre Fabre Mdicament Business Overview
11.16.3 Pierre Fabre Mdicament Fibromyalgia Therapeutics Introduction
11.16.4 Pierre Fabre Mdicament Revenue in Fibromyalgia Therapeutics Business (2017-2022)
11.16.5 Pierre Fabre Mdicament Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer